A new drug currently known as NG101 reduced nausea and vomiting in patients with obesity using GLP-1s by 40% and 67%:

Our final issue of the year is here! Pick up your December copy or read online for coverage including:
❄️FMT benefits in treating C diff
❄️Member spotlight on Dr. Andrew Ofosu
❄️In Focus on implementing weight management in practice

Read more: ow.ly/LIjG50XA52q

Duvakitug, a novel anti-TL1a antibody, showed potential for adults with Crohn's disease, a study presented at #ACG2025 found. Learn more 👉

Pediatric Wilson’s disease 🔗linked to higher risk and worse outcomes compared with adults, according to a new study in @aga-ghadvances.bsky.social: ow.ly/lH9050XrUzs

“Patients often raise questions about colonics or detox teas, especially when these gain traction on social media platforms like TikTok." — Tauseef Ali, MD, AGAF

How should GIs approach this conversation about colon cleanses? We spoke to @bilalmohammadmd.bsky.social and more: ow.ly/Vsih50XnUNu

AI in Gastroenterology and Endoscopy | MDedge In this issue of Perspectives, we present two timely essays that explore how AI is reshaping clinical care—while also emphasizing the need for caution, thoughtf

In this month's Perspectives column, we explore how AI is reshaping clinical care — while also emphasizing the need for caution, thoughtful integration, and ongoing oversight.

Dr. Manol Jovani is our November member spotlight! In an interview, Dr. Jovani discusses third space endoscopy, his advice for aspiring med students, and where he sees the #GI field going in the next 5 years.

👉https://ow.ly/6G7n50Xnfbk

This study published in @AmJGastro found that cold snare usage for removing small polyps was lower than expected for U.S. endoscopists, despite being the recommended method. ow.ly/7bH550XnVlM

Our November issue is live! Don't miss our articles on:
⭐Member spotlight
⭐Physician payment gains and gaps
⭐Clinical implications of the new liver nomenclature
⭐Perspectives on AI in #GI and endoscopy

Read now: ow.ly/ErcI50Xnf0g

The @fda.gov expands Rinvoq's use for #IBD: Now approved for adults with moderate-to-severe #UC or Crohn’s who’ve tried ≥1 systemic therapy — no need to fail a TNF blocker first. www.mdedge.com/gihepnews/ar...

Half of Patients Skip Repeat Stool Tests for CRC Screening | MDedge fewer than half of adults who started colorectal cancer (CRC) screening with an at-home stool test completed the recommended repeat test, creating gaps in prote

🆕 study in BMJ Public Health finds less than half of adults who start #CRC screening with an at-home stool test completed the recommended repeat test, But “the best CRC screening test is the one that gets done,” said author Dr. Staci J. Wendt.

From @aga-cgh.bsky.social: anti-TNF antagonists may weaken the benefit of some advanced therapies for #UC, while enhancing the efficacy of others.

From #UEGWeek: Dr. Maria Effenberg highlighted clinical implications of the new liver disease nomenclature and discussed pros and cons. @myueg.bsky.social ow.ly/wb9Q50XbQNx

Is AI Use Causing Endoscopists to Lose Their Skills? | MDedge Routine use of artificial intelligence (AI) may lead to a loss of skills among clinicians who perform colonoscopies, thereby affecting patient outcomes

Is #AI causing endoscopists to lose their skills? We spoke to lead authors from the study published in @lancetgastrohep.bsky.social.

➡️

Our October member spotlight is Dr. Pascale M. White! Dr. White discusses her mission to connect with communities to improve screening rates for colorectal cancer, her position as co-founder of ABGH, and more in our interview: ow.ly/Ay8N50XbRwb

🎃 Have you read our October issue yet? This month, we summarize global guidelines for pregnancy and #IBD, provide an update on the FDA approval of semaglutide for MASH with fibrosis, and highlight member spotlight Dr. Pascale M. White.

📰 Read now: ow.ly/UxnR50XbQxv

In this video from The New Gastroenterologist and DHPA, Dr. Peter Naas shares advice for young GIs starting a career in private practice gastroenterology. 🎥 Watch now: ow.ly/NSlx50WNKMj

To be an effective #GI consultant, Dr. Allon Kahn advises being the following 5️⃣ things: kind, timely, specific, helpful and honest.

Read more of his tips for The New Gastroenterologist: ow.ly/eEPa50WNKKV

More than 10% of GIs may face a malpractice claim, but it’s rarely discussed in med school. For The New Gastroenterologist, Dr. Koushik Das explains what malpractice is, the timeline of a lawsuit, and other consequences you might need to know. 👉 ow.ly/YaO950WNKJh

In this month's Perspectives column, Dr. Anahita Rabiee and Dr. Tarek Sawa discuss approaches to esophageal varices and Barrett’s esophagus, highlighting shifts in screening, surveillance, & innovation in GI care.

🔗 Read more: ow.ly/gMiq50WRtGz

#GLP1 has become a cornerstone in diabetes in weight loss management. For The New Gastroenterologist, Dr. Nikiya Asamoah & Dr. Sitharthan Sekar review current evidence and guidelines for GLP-1 use for endoscopic procedures ➡️ ow.ly/nZet50WNKHC

Exocrine pancreatic insufficiency is a challenging diagnosis. In this month’s In Focus, review how to approach diagnosing and treating EPI, plus screening for complications. www.mdedge.com/gihepnews/ar...

The latest issue of The New Gastroenterologist is live! In this issue, we cover exocrine pancreatic insufficiency, GLP-1 use, medical malpractice lawsuits and more. ow.ly/40bJ50WNKEQ

🖤 Ready to be inspired and uplifted? #ABGHNexus2025 is bringing together Black women in medicine for an unforgettable experience Oct. 3–5 at The Times Center, NYC! Join ABGH for connection, growth, and empowerment—register by Sept. 19 to save! #BlackWomenInMedicine whova.com/portal/regis...

Our September member spotlight is @jessicakormanmd.bsky.social, whose mission is to reduce the stigma around anal cancer.

“I think GIs are uniquely positioned to help with diagnosing anal diseases. It is part of the digestive tract." Read ➡️ ow.ly/GGlw50WQCqc

New #IBS in America survey reveals that IBS symptoms continue to disrupt lives — an average of 19 days each month. ow.ly/5Ij650WOeEK

The @fda.gov has approved @novonordisk.bsky.social's Wegovy for treating MASH in adults with fibrosis but without cirrhosis. Learn more: www.mdedge.com/gihepnews/ar...

A new @aga-gastro.bsky.social clinical practice update, published in @aga-cgh.bsky.social, offers guidance for identifying GI symptoms in patients with hypermobile Ehlers-Danlos syndrome. ➡️ ow.ly/NsGz50WNKtq

Happy September! ✏️🍎 Be sure to check out this month's new issue, including:
✔️Member spotlight on Dr. Jessica Korman
✔️5 tips on becoming a GI consultant by
✔️Colonoscopy screening effective in 45- to 49-year-olds

Read more: ow.ly/LJeT50WPzkH

Follow-up colonoscopies are low after blood-based CRC screening, raising concerns about missed diagnoses. New research led by Dr. Timothy Zaki in @aga-gastro.bsky.social highlights the need for better patient education and system-level interventions. ➡️